Kronox Lab

Market Cap: Micro Cap
Industry: Specialty Chemicals
ISIN: INE0ATZ01017
NSEID: KRONOX
BSEID: 544187

INR

143.80

3.45 (2.46%)

BSENSE

Dec 15

BSE+NSE Vol: 51.2 k

{
  "main_header": {
    "sid": 10039273,
    "name": "Kronox Lab",
    "stock_name": "Kronox Lab",
    "full_name": "Kronox Lab Sciences Ltd",
    "name_url": "stocks-analysis/kronox-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "143.80",
    "chg": 3.45,
    "chgp": "2.46%",
    "dir": 1,
    "prev_price": "140.35",
    "mcapval": "525.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544187,
    "symbol": "KRONOX",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE0ATZ01017",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "51.2 k",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kronox-lab-10039273-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kronox Lab Sciences Stock Falls to 52-Week Low of Rs.129.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kronox-lab-sciences-stock-hits-52-week-low-amidst-prolonged-underperformance-3753850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KronoxLabScienc_priceRelatedfactors_3753850.png",
        "date": "2025-12-09 11:39:34",
        "description": "Kronox Lab Sciences, a player in the Specialty Chemicals sector, recorded a new 52-week low of Rs.129.95 today, marking a significant price level for the stock amid a broader market environment where the Sensex opened lower and small caps showed relative strength."
      },
      {
        "title": "Kronox Lab Sciences Stock Hits All-Time Low Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kronox-lab-sciences-stock-hits-all-time-low-amid-prolonged-underperformance-3753772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KronoxLabScienc_priceRelatedfactors_3753772.png",
        "date": "2025-12-09 11:08:16",
        "description": "Kronox Lab Sciences, a player in the Specialty Chemicals sector, recorded a new 52-week and all-time low of ₹129.95 today, marking a significant milestone in its recent market trajectory. This development comes amid a series of declines over the past year, reflecting ongoing challenges in both short-term and long-term performance metrics."
      },
      {
        "title": "Why is Kronox Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kronox-lab-fallingrising-3752582",
        "imagepath": "",
        "date": "2025-12-09 01:27:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Underperformance Against Benchmarks</strong></p>\n<p>Kronox Lab’s recent performance starkly contrasts with the broader market indices. Over the past week, the stock has declined by 6.76%, significantly underperforming the Sensex, which fell by only 0.63% during the same period. The divergence is even more pronounced over longer horizons, with the stock down 9.28% in the last month while the Sensex gained 2.27%. Year-to-date, Kronox Lab has plummeted 33.45%, whereas the Sensex has appreciated by 8.91%. This trend extends to the one-year mark, where the stock has lost 34.78% compared to the Sensex’s 4.15% gain. Such sustained underperformance highlights the challenges facing the company relative to the broader market.</p>\n<p><strong>Technical Indicators Signal Continued Weakness</st..."
      },
      {
        "title": "Kronox Lab Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kronox-lab-downgraded-to-sell-by-marketsmojo-amid-valuation-and-technical-concerns-3738110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KronoxLab_mojoScore_3738110.png",
        "date": "2025-12-01 10:09:02",
        "description": "Kronox Lab, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid subdued stock performance and valuation concerns, highlighting the challenges faced by the company in maintaining investor confidence."
      },
      {
        "title": "How has been the historical performance of Kronox Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kronox-lab-3695818",
        "imagepath": "",
        "date": "2025-11-13 00:41:22",
        "description": "Answer:\nThe historical performance of Kronox Lab shows a consistent growth in net sales and profitability over the past four years.\n\nBreakdown:\nKronox Lab's net sales have increased from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25, reflecting a positive growth trend. The total operating income followed a similar trajectory, rising from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated significant growth, moving from 20.79 Cr in Mar'22 to 35.65 Cr in Mar'25, with an operating profit margin of 33.06% in the latest fiscal year. Profit before tax increased from 18.36 Cr in Mar'22 to 34.27 Cr in Mar'25, while profit after tax rose from 13.63 Cr to 25.47 Cr during the same period, resulting in a PAT margin of 25.42% in Mar'25. On the balance sheet, total assets grew from 56.46 Cr in Mar'22 to 98.43 Cr in Mar'25, with total liabilities increasing from 56.46 Cr to 98...."
      },
      {
        "title": "Are Kronox Lab latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-kronox-lab-latest-results-good-or-bad-3693272",
        "imagepath": "",
        "date": "2025-11-12 19:36:04",
        "description": "Kronox Lab Sciences has reported its financial results for Q2 FY26, showcasing a company that is managing operational challenges with a focus on margin preservation, despite limited revenue growth. The net profit for the quarter was ₹6.68 crores, reflecting a sequential increase of 6.37% and a year-on-year rise of 3.24%. Revenue for the same period reached ₹25.53 crores, which represents a 5.10% increase from the previous quarter and a modest 2.70% gain compared to the same quarter last year. \n\nThe operating margin, excluding other income, improved to 33.84%, marking the highest level in the last seven quarters, which indicates effective cost management and operational efficiency. The profit after tax (PAT) margin was reported at 26.17%, also among the strongest in recent history for the company. \n\nHowever, the overall revenue growth remains subdued, with a half-yearly performance showing a slight decline o..."
      },
      {
        "title": "Kronox Lab Sciences Q2 FY26: Margin Strength Masks Muted Growth Amid Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/kronox-lab-sciences-q2-fy26-margin-strength-masks-muted-growth-amid-valuation-concerns-3692869",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KronoxLabScienc_quaterlyResult_3692869.png",
        "date": "2025-11-12 09:56:56",
        "description": "Kronox Lab Sciences Ltd., a micro-cap specialty chemicals manufacturer, reported a modest quarter in Q2 FY26, with net profit rising to ₹6.68 crores—a sequential increase of 6.37% quarter-on-quarter (QoQ) and 3.24% year-on-year (YoY). With a market capitalisation of ₹546.91 crores, the Ahmedabad-based company continues to demonstrate operational resilience through strong margins, yet faces headwinds from tepid revenue growth and an increasingly bearish market sentiment. The stock closed at ₹147.40 on November 12, 2025, down 0.84% on the day, reflecting investor caution following the results announcement."
      },
      {
        "title": "Why is Kronox Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kronox-lab-fallingrising-3687442",
        "imagepath": "",
        "date": "2025-11-11 00:25:46",
        "description": "As of 10-Nov, Kronox Lab Sciences Ltd is experiencing a decline in its stock price, currently at Rs 143.45, which reflects a decrease of Rs 2.6 or 1.78%. The stock has underperformed its sector by 1.02% today and reached an intraday low of Rs 143.05, indicating a downward trend. Over the past week, the stock has decreased by 2.08%, and its performance over the last month shows a significant decline of 5.63%. Year-to-date, the stock has fallen by 27.95%, while its one-year return is down by 15.69%. Additionally, Kronox Lab is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent bearish trend. There is also a notable decrease in investor participation, with delivery volume falling by 2.3% compared to the 5-day average, indicating waning interest in the stock.\n\nIn the broader market context, the Sensex has shown a relatively stable performance, with a slight de..."
      },
      {
        "title": "Why is Kronox Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kronox-lab-fallingrising-3608635",
        "imagepath": "",
        "date": "2025-10-10 00:16:28",
        "description": "As of 09-Oct, Kronox Lab Sciences Ltd is experiencing a decline in its stock price, currently at 150.50, which represents a decrease of 3.15 or 2.05%. The stock has been underperforming, having fallen consecutively for the last five days, with a total return of -6.93% over that period. Today, it opened with a loss of 2.25% and reached an intraday low of Rs 147.25, reflecting a decline of 4.17%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. There is a noticeable drop in investor participation, with delivery volume decreasing by 5.25% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.\n\nIn the broader market context, Kronox Lab's performance has significantly lagged behind the benchmark, with a year-to-date return of -24.41% compared to the Sensex's gain of 5.16%. Ove..."
      }
    ],
    "total": 142,
    "sid": "10039273",
    "stock_news_url": "https://www.marketsmojo.com/news/kronox-lab-sciences-10039273"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2025",
      "details": "Newspaper Announcement for Un-audited Financial Results for the Quarter and Half Year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today",
      "datetime": "11-Nov-2025",
      "details": "Outcome of Board Meeting held today to consider Unaudited Financial Results for the Quarter and Half year ended September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 2025",
      "datetime": "11-Nov-2025",
      "details": "Board Meeting held today to consider Unaudited Financial Results for the Quarter and Half Year ended September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kronox Lab Sciences Ltd has declared <strong>5%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kronox Lab Sciences Stock Falls to 52-Week Low of Rs.129.95

2025-12-09 11:39:34

Kronox Lab Sciences, a player in the Specialty Chemicals sector, recorded a new 52-week low of Rs.129.95 today, marking a significant price level for the stock amid a broader market environment where the Sensex opened lower and small caps showed relative strength.

Kronox Lab Sciences Stock Hits All-Time Low Amidst Prolonged Underperformance

2025-12-09 11:08:16

Kronox Lab Sciences, a player in the Specialty Chemicals sector, recorded a new 52-week and all-time low of ₹129.95 today, marking a significant milestone in its recent market trajectory. This development comes amid a series of declines over the past year, reflecting ongoing challenges in both short-term and long-term performance metrics.

Why is Kronox Lab falling/rising?

2025-12-09 01:27:26

Persistent Underperformance Against Benchmarks

Kronox Lab’s recent performance starkly contrasts with the broader market indices. Over the past week, the stock has declined by 6.76%, significantly underperforming the Sensex, which fell by only 0.63% during the same period. The divergence is even more pronounced over longer horizons, with the stock down 9.28% in the last month while the Sensex gained 2.27%. Year-to-date, Kronox Lab has plummeted 33.45%, whereas the Sensex has appreciated by 8.91%. This trend extends to the one-year mark, where the stock has lost 34.78% compared to the Sensex’s 4.15% gain. Such sustained underperformance highlights the challenges facing the company relative to the broader market.

Technical Indicators Signal Continued WeaknessRead More

Kronox Lab Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges
2025-12-01 10:09:02
Kronox Lab, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid subdued stock performance and valuation concerns, highlighting the challenges faced by the company in maintaining investor confidence.
Read More

How has been the historical performance of Kronox Lab?
2025-11-13 00:41:22
Answer: The historical performance of Kronox Lab shows a consistent growth in net sales and profitability over the past four years. Breakdown: Kronox Lab's net sales have increased from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25, reflecting a positive growth trend. The total operating income followed a similar trajectory, rising from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated significant growth, moving from 20.79 Cr in Mar'22 to 35.65 Cr in Mar'25, with an operating profit margin of 33.06% in the latest fiscal year. Profit before tax increased from 18.36 Cr in Mar'22 to 34.27 Cr in Mar'25, while profit after tax rose from 13.63 Cr to 25.47 Cr during the same period, resulting in a PAT margin of 25.42% in Mar'25. On the balance sheet, total assets grew from 56.46 Cr in Mar'22 to 98.43 Cr in Mar'25, with total liabilities increasing from 56.46 Cr to 98....
Read More

Are Kronox Lab latest results good or bad?
2025-11-12 19:36:04
Kronox Lab Sciences has reported its financial results for Q2 FY26, showcasing a company that is managing operational challenges with a focus on margin preservation, despite limited revenue growth. The net profit for the quarter was ₹6.68 crores, reflecting a sequential increase of 6.37% and a year-on-year rise of 3.24%. Revenue for the same period reached ₹25.53 crores, which represents a 5.10% increase from the previous quarter and a modest 2.70% gain compared to the same quarter last year. The operating margin, excluding other income, improved to 33.84%, marking the highest level in the last seven quarters, which indicates effective cost management and operational efficiency. The profit after tax (PAT) margin was reported at 26.17%, also among the strongest in recent history for the company. However, the overall revenue growth remains subdued, with a half-yearly performance showing a slight decline o...
Read More

Kronox Lab Sciences Q2 FY26: Margin Strength Masks Muted Growth Amid Valuation Concerns
2025-11-12 09:56:56
Kronox Lab Sciences Ltd., a micro-cap specialty chemicals manufacturer, reported a modest quarter in Q2 FY26, with net profit rising to ₹6.68 crores—a sequential increase of 6.37% quarter-on-quarter (QoQ) and 3.24% year-on-year (YoY). With a market capitalisation of ₹546.91 crores, the Ahmedabad-based company continues to demonstrate operational resilience through strong margins, yet faces headwinds from tepid revenue growth and an increasingly bearish market sentiment. The stock closed at ₹147.40 on November 12, 2025, down 0.84% on the day, reflecting investor caution following the results announcement.
Read More

Why is Kronox Lab falling/rising?
2025-11-11 00:25:46
As of 10-Nov, Kronox Lab Sciences Ltd is experiencing a decline in its stock price, currently at Rs 143.45, which reflects a decrease of Rs 2.6 or 1.78%. The stock has underperformed its sector by 1.02% today and reached an intraday low of Rs 143.05, indicating a downward trend. Over the past week, the stock has decreased by 2.08%, and its performance over the last month shows a significant decline of 5.63%. Year-to-date, the stock has fallen by 27.95%, while its one-year return is down by 15.69%. Additionally, Kronox Lab is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent bearish trend. There is also a notable decrease in investor participation, with delivery volume falling by 2.3% compared to the 5-day average, indicating waning interest in the stock. In the broader market context, the Sensex has shown a relatively stable performance, with a slight de...
Read More

Why is Kronox Lab falling/rising?
2025-10-10 00:16:28
As of 09-Oct, Kronox Lab Sciences Ltd is experiencing a decline in its stock price, currently at 150.50, which represents a decrease of 3.15 or 2.05%. The stock has been underperforming, having fallen consecutively for the last five days, with a total return of -6.93% over that period. Today, it opened with a loss of 2.25% and reached an intraday low of Rs 147.25, reflecting a decline of 4.17%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. There is a noticeable drop in investor participation, with delivery volume decreasing by 5.25% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors impacting the stock. In the broader market context, Kronox Lab's performance has significantly lagged behind the benchmark, with a year-to-date return of -24.41% compared to the Sensex's gain of 5.16%. Ove...
Read More

View All News